m+Medelevator.RU
← Поиск публикаций
Cognitive behaviour therapy · 2026

The effects of intensive mindfulness meditation training on mental health: evidence of effectiveness and safety from a matched-controlled intervention study.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Hadash Yuval, Dar Omer, Oren-Schwartz Romi, Bernstein Amit

Аннотация

Despite increased public interest and research on intensive high-dose mental health interventions, much remains unknown about the mental health effects and safety of multi-day intensive high-dose mindfulness meditation training. Accordingly, we conducted a preregistered prospective intervention study among 89 adults who registered for 6-day insight mindfulness meditation retreats and 46 matched controls (Mage(SDage) = 33.75 (9.50), 56.3% female). Retreat participants demonstrated significant improvements in well-being, negative affect, perseverative thinking, brooding rumination, and depression symptoms at 2-week follow-up compared to matched controls (η2 range = .04-.08, ps < .05). Effects on positive affect, emotion regulation, and anxiety symptoms were not significant. The percentage of participants exhibiting statistically reliable deterioration in mental health at 2-week follow-up was equal or lower among retreat participants than matched controls, both in the full sample and in a subsample with clinically elevated depression and/or anxiety (ORs < 1). Findings suggest that a 6-day mindfulness meditation retreat can produce rapid improvements in mental health, comparable to effect sizes of much longer 8-week mindfulness-based programs. Findings also challenge concerns about adverse effects of intensive high-dose meditation retreats and suggest they may be a safe and effective intervention modality, even for clinically vulnerable adults struggling with depression or anxiety.Trial Registration: ClinicalTrials.gov registration ID NCT04749264.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты